NCT04498871 MAP to Provide Access to Nilotinib, for Patients With HES Status NO_LONGER_AVAILABLE Phase N/A
NCT04491136 Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM) Status TERMINATED Phase PHASE4
NCT04489433 Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma Status NO_LONGER_AVAILABLE Phase N/A
NCT04488185 An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound Status WITHDRAWN Phase PHASE4
NCT04486716 A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT04485559 Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) Status SUSPENDED Phase PHASE1
NCT04480853 Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis Status RECRUITING Phase PHASE4
NCT04473040 Managed Access Program to Provide Access to Alpelisib for Patients With Advanced Breast Cancer Status AVAILABLE Phase N/A
NCT04460729 A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases Status WITHDRAWN Phase PHASE2
NCT04456023 Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL) Status WITHDRAWN Phase PHASE2
NCT04452929 The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients Status UNKNOWN Phase NA
NCT04452877 A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC Status COMPLETED Phase PHASE2
NCT04443907 Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD) Status TERMINATED Phase PHASE1
NCT04437368 EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Status TERMINATED Phase PHASE2
NCT04427072 Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation Status TERMINATED Phase PHASE3
NCT04419259 Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea Status UNKNOWN Phase PHASE2
NCT04417621 Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04410523 Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Status TERMINATED Phase PHASE2
NCT04408937 The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor. Status COMPLETED Phase PHASE1